Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
Husam M. Salah, Abdul Mannan Khan Minhas, Muhammad Shahzeb Khan, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 2, pp. 947-952
Open Access | Times Cited: 25

Showing 25 citing articles:

Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
Biykem Bozkurt, Tariq Ahmad, Kevin Alexander, et al.
Journal of Cardiac Failure (2023) Vol. 29, Iss. 10, pp. 1412-1451
Open Access | Times Cited: 319
Global epidemiology of heart failure
Muhammad Shahzeb Khan, Izza Shahid, Ahmed Bennis, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 10, pp. 717-734
Closed Access | Times Cited: 56
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
Biykem Bozkurt, Tariq Ahmad, Kevin Alexander, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 30
Heart Failure Statistics 2024 Update: A Report From the Korean Society of Heart Failure
Chan Joo Lee, Hokyou Lee, Minjae Yoon, et al.
International Journal of Heart Failure (2024) Vol. 6, Iss. 2, pp. 56-56
Open Access | Times Cited: 19
Intravenous iron infusion in patients with heart failure: a systematic review and study‐level meta‐analysis
Husam M. Salah, Gianluigi Savarese, Giuseppe Rosano, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 2, pp. 1473-1480
Open Access | Times Cited: 38
Predicting in‐hospital mortality among patients admitted with a diagnosis of heart failure: a machine learning approach
Zina Jawadi, Rosemary He, Pratyaksh K. Srivastava, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 2490-2498
Open Access | Times Cited: 5
The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022
Rosa María Gómez-García, R Jiménez-García, Ana López‐de‐Andrés, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 516-516
Open Access
Device Interventions for Heart Failure
Husam M. Salah, Marat Fudim, Daniel Burkhoff
JACC Heart Failure (2023) Vol. 11, Iss. 8, pp. 1039-1054
Open Access | Times Cited: 9
Management and Outcomes of Acute Heart Failure Hospitalizations in Japan
Koshiro Kanaoka, Yoshitaka Iwanaga, Yoko Sumita, et al.
Circulation Journal (2023) Vol. 88, Iss. 8, pp. 1265-1273
Open Access | Times Cited: 8
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2021
Manyoo Agarwal, Gregg C. Fonarow, Boback Ziaeian
JACC Heart Failure (2024) Vol. 13, Iss. 1, pp. 175-178
Open Access | Times Cited: 2
A National Perspective on the Impact of the COVID-19 Pandemic on Heart Failure Hospitalizations in the United States
Tushar Subhadarshan Mishra, Dhruvil Ashishkumar Patel, Abdalaziz Awadelkarim, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101749-101749
Open Access | Times Cited: 6
Trends in heart failure-related mortality among middle-aged adults in the United States from 1999-2022
Ali Bin Abdul Jabbar, M. Le May, McKayla Deisz, et al.
Current Problems in Cardiology (2024), pp. 102973-102973
Open Access | Times Cited: 2
Gefapixant, a Novel P2X3 Antagonist, Protects against Post Myocardial Infarction Cardiac Dysfunction and Remodeling Via Suppressing NLRP3 Inflammasome
Yanzhao Wei, Shuang Yang, Wei Li, et al.
Current Medical Science (2023) Vol. 43, Iss. 1, pp. 58-68
Closed Access | Times Cited: 5
Emerging devices for heart failure management
Fouad Chouairi, A.P. Levin, Jan Biegus, et al.
Progress in Cardiovascular Diseases (2024) Vol. 82, pp. 125-134
Closed Access | Times Cited: 1
Exploring Heart Failure Mortality Trends and Disparities in Women: A Retrospective Cohort Analysis
Ramzi Ibrahim, Mahek Shahid, Min Choon Tan, et al.
The American Journal of Cardiology (2023) Vol. 209, pp. 42-51
Closed Access | Times Cited: 3
Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019
Aleezay Asghar, Khawaja M. Talha, Eisha Waqar, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 2, pp. 102342-102342
Closed Access | Times Cited: 3
Ten Questions and Some Reflections about Palliative Care in Advanced Heart Failure Patients
Massimo Romanò
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6933-6933
Open Access | Times Cited: 4
Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey
Khawaja M. Talha, Talal Almas, Abdul Mannan Khan Minhas, et al.
Therapeutic Advances in Cardiovascular Disease (2024) Vol. 18
Open Access
Long-term risk of hospitalization and death in patients with mechanical prosthetic heart valves.
Ilaria Palumbo, Danilo Menichelli, Flavio Giuseppe Biccirè, et al.
The American Journal of Cardiology (2024) Vol. 228, pp. 16-23
Closed Access
The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients
Berenika Jankowiak, Marta Wleklik, Marta Rosiek‐Biegus
Vaccines (2024) Vol. 12, Iss. 12, pp. 1321-1321
Open Access
Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022
Valérie Olié, Richard Isnard, Françoise Pousset, et al.
ESC Heart Failure (2024)
Closed Access
Tolerability and safety barriers to sodium–glucose cotransporter 2 inhibitor initiation in heart failure with reduced ejection fraction
Husam M. Salah, Marat Fudim
European Journal of Heart Failure (2022) Vol. 24, Iss. 9, pp. 1633-1635
Open Access | Times Cited: 1
Cost-Effectiveness of Systematic Screening and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) in United States
Anson T.C. Lau, Robert J. DiDomenico, Kibum Kim
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Pathophysiology of Hypertensive Heart Disease
Cesare Cuspidi, Marijana Tadić, Carla Sala, et al.
Updates in hypertension and cardiovascular protection (2023), pp. 229-241
Closed Access
Page 1

Scroll to top